Drug Type Antibody |
Synonyms ND BT3814, NDBT3814 |
Target |
Mechanism TDP43 modulators(TAR DNA binding protein 43 modulators) |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Amyotrophic Lateral Sclerosis | Preclinical | SE | 12 Apr 2024 |